Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How We Collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Novel High-Resolution Lipidomes Could Serve as New Biomarkers for Diabetic Retinopathy: A Bidirectional and Mediated Mendelian Randomization Study

Submitted by Frida Mäkelä on Wed, 06/04/2025 - 17:35
  • Read more about Novel High-Resolution Lipidomes Could Serve as New Biomarkers for Diabetic Retinopathy: A Bidirectional and Mediated Mendelian Randomization Study

NFKB1-targeted metabolites as novel therapeutic approaches for erectile dysfunction: evidence from gut microbiota network pharmacology and machine learning

Submitted by Frida Mäkelä on Wed, 06/04/2025 - 17:25
  • Read more about NFKB1-targeted metabolites as novel therapeutic approaches for erectile dysfunction: evidence from gut microbiota network pharmacology and machine learning

Therapeutic Targets for Sepsis: Multicenter Proteome-Wide Analyses and Experimental Validation

Submitted by Frida Mäkelä on Wed, 06/04/2025 - 17:10
  • Read more about Therapeutic Targets for Sepsis: Multicenter Proteome-Wide Analyses and Experimental Validation

Cross-Tissue Transcriptome-Wide Association Study Identifies Novel Genes Associated With POAG

Submitted by Frida Mäkelä on Wed, 06/04/2025 - 16:46
  • Read more about Cross-Tissue Transcriptome-Wide Association Study Identifies Novel Genes Associated With POAG

Corneal Biomechanics as a Causal Factor in Myopia and Astigmatism: Evidence from Mendelian Randomization

Submitted by Frida Mäkelä on Wed, 06/04/2025 - 16:36
  • Read more about Corneal Biomechanics as a Causal Factor in Myopia and Astigmatism: Evidence from Mendelian Randomization

Unveiling the Intricate Causal Nexus Between 91 Circulating Inflammatory Proteins and Perianal Abscess Through a Comprehensive Bidirectional Two-Sample Mendelian Randomization Analysis

Submitted by Frida Mäkelä on Wed, 06/04/2025 - 16:28
  • Read more about Unveiling the Intricate Causal Nexus Between 91 Circulating Inflammatory Proteins and Perianal Abscess Through a Comprehensive Bidirectional Two-Sample Mendelian Randomization Analysis

Genetic analysis of the correlation between GLP1 action and metabolic liver disease: Insights from Mendelian randomization analysis

Submitted by Frida Mäkelä on Wed, 06/04/2025 - 16:13
  • Read more about Genetic analysis of the correlation between GLP1 action and metabolic liver disease: Insights from Mendelian randomization analysis

Identification of novel therapeutic targets for atrial fibrillation through Mendelian randomization analysis of druggable genes

Submitted by Frida Mäkelä on Wed, 06/04/2025 - 16:01
  • Read more about Identification of novel therapeutic targets for atrial fibrillation through Mendelian randomization analysis of druggable genes

Identification of EPHB4 as a potential causal gene and therapeutic target for endometriosis using Mendelian randomization

Submitted by Frida Mäkelä on Wed, 06/04/2025 - 15:46
  • Read more about Identification of EPHB4 as a potential causal gene and therapeutic target for endometriosis using Mendelian randomization

Causal relationship between immune cells and post-viral fatigue syndrome: a Mendelian randomization study

Submitted by Frida Mäkelä on Wed, 06/04/2025 - 15:36
  • Read more about Causal relationship between immune cells and post-viral fatigue syndrome: a Mendelian randomization study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 109
  • Page 110
  • Page 111
  • Page 112
  • Current page 113
  • Page 114
  • Page 115
  • Page 116
  • Page 117
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement